# Neil Mahapatra

> Neil Mahapatra is a seed investor at Kingsley Capital Partners backing Medical and Cannabis. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Kingsley Capital Partners](https://shizune.co/investors/profile/kingsley-capital-partners)
- Location: London, United Kingdom
- Total investments: 5
- Last investment: Feb 2024
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/neil-mahapatra-2818141
- Facebook: https://www.facebook.com/neil.mahapatra

Neil Mahapatra is a seed investor at Kingsley Capital Partners in London focused on Medical and Cannabis. Neil Mahapatra is the Founder and Managing Partner of Kingsley Capital Partners. He Previously worked at J. Rothschild Capital Management as a Private Equity Executive. Neil Mahapatra attended Harvard Business School.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 20% |
| Cannabis | 1 | 20% |
| Biotechnology | 1 | 20% |
| Pharmaceutical | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 60% |
| Funding Round | 1 | 20% |
| Post-IPO Debt | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oxford Cannabinoid Technologies | Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need. | $713.8K | Post-IPO Debt | Feb 02, 2024 |  |
| Spring Fibre |  |  | Seed |  |  |
| Atlas Tower Group | Atlas Tower Group is a wireless infrastructure solution provider specialized in designing towers and rooftops that are 5G ready. |  | Seed |  |  |
| Equinox International | Equinox is a cannabis company focused on developing pharmaceutical quality products. |  | Seed |  |  |
| Oxford Cannabinoid Technologies | Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need. |  |  |  |  |

5 of 5 investments shown.

## Co-investors
- [Cantheon Capital](https://shizune.co/investors/profile/cantheon-capital) — VC Fund, 1 deal together

## About Kingsley Capital Partners

VC Fund



1 contacts available at Kingsley Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Neil Mahapatra | Managing Partner | https://shizune.co/investors/profile/neil-mahapatra |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Neil Mahapatra invest in?

Neil Mahapatra invests primarily in Medical, Cannabis and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Neil Mahapatra last invest?

The most recent investment recorded for Neil Mahapatra closed in Feb 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co